May 11, 2011 -The American Society of Echocardiography (ASE) will host its 22nd Annual Scientific Sessions: The Patient the Image: The Role of Cardiovascular Ultrasound in Clinical Decision Making (ASE 2011), June 11-14 at the Palais des Congres de Montreal in Montreal, Quebec, Canada.

May 10, 2011 – The Impella percutaneously deployed ventricular assist device showed an overall average hospital charge savings when compared to the standard-of-care intra-aortic balloon pump (IABP). The economic analyses is based on data from the PROTECT II study, which compares Impella to IABP hemodynamic support.

specialist in medical imaging solutions


May 11, 2011 – Terumo entered into a purchase agreement to acquire Harvest Technologies Corp, which is working to commercialize the world's first point-of-care stem cell therapy.

May 10, 2011 – Patients suffering from blockages of the arteries to the kidneys now have access to a new stenting treatment option with the launch of Cook Medical’s Formula Renal Balloon-Expandable Stent at the Society for Cardiovascular Angioplasty and Intervention (SCAI) 2011 Scientific Sessions. Commercial availability of Formula follows pre-market approval by the U.S. Food and Drug Administration (FDA) earlier this year for use in patients with atherosclerotic disease of the renal arteries.

May 10, 2011 – A simple blood test may help prevent a serious complication associated with a contrast agent commonly used in MRI exams, according to a study published in the July issue of Radiology.

May 10, 2011 – Thirty Society of Nuclear Medicine (SNM) members visited Capitol Hill on May 2 to meet with congressional offices on a variety of issues facing the nuclear medicine and molecular imaging community. Forty-eight meetings were held with staff members from key congressional committees and from the local districts of the SNM members.

May 10, 2011 – The world's smallest and thinnest high-energy cardiac resynchronization therapy defibrillators (CRT-Ds) and implantable cardioverter defibrillators (ICDs) to treat heart failure and sudden cardiac death and offer excellent longevity were launched this week in Europe. Boston Scientific Corp. announced the launch and first implants of its Energen and Punctua CRT-Ds and ICDs in Europe and other international markets.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now